BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 32776697)

  • 21. Congenital myasthenic syndrome with tubular aggregates caused by GFPT1 mutations.
    Guergueltcheva V; Müller JS; Dusl M; Senderek J; Oldfors A; Lindbergh C; Maxwell S; Colomer J; Mallebrera CJ; Nascimento A; Vilchez JJ; Muelas N; Kirschner J; Nafissi S; Kariminejad A; Nilipour Y; Bozorgmehr B; Najmabadi H; Rodolico C; Sieb JP; Schlotter B; Schoser B; Herrmann R; Voit T; Steinlein OK; Najafi A; Urtizberea A; Soler DM; Muntoni F; Hanna MG; Chaouch A; Straub V; Bushby K; Palace J; Beeson D; Abicht A; Lochmüller H
    J Neurol; 2012 May; 259(5):838-50. PubMed ID: 21975507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of a new SYT2 variant validates an unusual distal motor neuropathy phenotype.
    Montes-Chinea NI; Guan Z; Coutts M; Vidal C; Courel S; Rebelo AP; Abreu L; Zuchner S; Littleton JT; Saporta MA
    Neurol Genet; 2018 Dec; 4(6):e282. PubMed ID: 30533528
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Choline transporter mutations in severe congenital myasthenic syndrome disrupt transporter localization.
    Wang H; Salter CG; Refai O; Hardy H; Barwick KES; Akpulat U; Kvarnung M; Chioza BA; Harlalka G; Taylan F; Sejersen T; Wright J; Zimmerman HH; Karakaya M; Stüve B; Weis J; Schara U; Russell MA; Abdul-Rahman OA; Chilton J; Blakely RD; Baple EL; Cirak S; Crosby AH
    Brain; 2017 Nov; 140(11):2838-2850. PubMed ID: 29088354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Electrophysiology of Presynaptic Congenital Myasthenic Syndromes With and Without Facilitation: From Electrodiagnostic Findings to Molecular Mechanisms.
    Nicolau S; Milone M
    Front Neurol; 2019; 10():257. PubMed ID: 30941097
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Congenital myasthenic syndrome caused by novel COL13A1 mutations.
    Dusl M; Moreno T; Munell F; Macaya A; Gratacòs M; Abicht A; Strom TM; Lochmüller H; Senderek J
    J Neurol; 2019 May; 266(5):1107-1112. PubMed ID: 30767057
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recessive variants of MuSK are associated with late onset CMS and predominant limb girdle weakness.
    Owen D; Töpf A; Preethish-Kumar V; Lorenzoni PJ; Vroling B; Scola RH; Dias-Tosta E; Geraldo A; Polavarapu K; Nashi S; Cox D; Evangelista T; Dawson J; Thompson R; Senderek J; Laurie S; Beltran S; Gut M; Gut I; Nalini A; Lochmüller H
    Am J Med Genet A; 2018 Jul; 176(7):1594-1601. PubMed ID: 29704306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Presynaptic Congenital Myasthenic Syndromes: Understanding Clinical Phenotypes through In vivo Models.
    Pugliese A; Holland SH; Rodolico C; Lochmüller H; Spendiff S
    J Neuromuscul Dis; 2023; 10(5):731-759. PubMed ID: 37212067
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuromuscular junction involvement in inherited motor neuropathies: genetic heterogeneity and effect of oral salbutamol treatment.
    McMacken G; Whittaker RG; Wake R; Lochmuller H; Horvath R
    J Neurol; 2023 Jun; 270(6):3112-3119. PubMed ID: 36869887
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Congenital Myasthenic Syndrome Type 19 Is Caused by Mutations in COL13A1, Encoding the Atypical Non-fibrillar Collagen Type XIII α1 Chain.
    Logan CV; Cossins J; Rodríguez Cruz PM; Parry DA; Maxwell S; Martínez-Martínez P; Riepsaame J; Abdelhamed ZA; Lake AV; Moran M; Robb S; Chow G; Sewry C; Hopkins PM; Sheridan E; Jayawant S; Palace J; Johnson CA; Beeson D
    Am J Hum Genet; 2015 Dec; 97(6):878-85. PubMed ID: 26626625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A common mutation (epsilon1267delG) in congenital myasthenic patients of Gypsy ethnic origin.
    Abicht A; Stucka R; Karcagi V; Herczegfalvi A; Horváth R; Mortier W; Schara U; Ramaekers V; Jost W; Brunner J; Janssen G; Seidel U; Schlotter B; Müller-Felber W; Pongratz D; Rüdel R; Lochmüller H
    Neurology; 1999 Oct; 53(7):1564-9. PubMed ID: 10534268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COLQ-related congenital myasthenic syndrome: An integrative view.
    Eshaghian T; Rabbani B; Badv RS; Mikaeeli S; Gharib B; Iyadurai S; Mahdieh N
    Neurogenetics; 2023 Jul; 24(3):189-200. PubMed ID: 37231228
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A spontaneous missense mutation in the chromodomain helicase DNA-binding protein 8 (CHD8) gene: a novel association with congenital myasthenic syndrome.
    Lee CY; Petkova M; Morales-Gonzalez S; Gimber N; Schmoranzer J; Meisel A; Böhmerle W; Stenzel W; Schuelke M; Schwarz JM
    Neuropathol Appl Neurobiol; 2020 Oct; 46(6):588-601. PubMed ID: 32267004
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective Treatment With Albuterol in DOK7 Congenital Myasthenic Syndrome in Children.
    Tsao CY
    Pediatr Neurol; 2016 Jan; 54():85-7. PubMed ID: 26552645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and molecular genetic findings in COLQ-mutant congenital myasthenic syndromes.
    Mihaylova V; Müller JS; Vilchez JJ; Salih MA; Kabiraj MM; D'Amico A; Bertini E; Wölfle J; Schreiner F; Kurlemann G; Rasic VM; Siskova D; Colomer J; Herczegfalvi A; Fabriciova K; Weschke B; Scola R; Hoellen F; Schara U; Abicht A; Lochmüller H
    Brain; 2008 Mar; 131(Pt 3):747-59. PubMed ID: 18180250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Congenital myasthenic syndromes.
    Eymard B; Hantaï D; Estournet B
    Handb Clin Neurol; 2013; 113():1469-80. PubMed ID: 23622369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and genetic basis of congenital myasthenic syndromes.
    Souza PV; Batistella GN; Lino VC; Pinto WB; Annes M; Oliveira AS
    Arq Neuropsiquiatr; 2016 Sep; 74(9):750-760. PubMed ID: 27706425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel delta subunit mutation in slow-channel syndrome causes severe weakness by novel mechanisms.
    Gomez CM; Maselli RA; Vohra BP; Navedo M; Stiles JR; Charnet P; Schott K; Rojas L; Keesey J; Verity A; Wollmann RW; Lasalde-Dominicci J
    Ann Neurol; 2002 Jan; 51(1):102-12. PubMed ID: 11782989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recessive VAMP1 mutations associated with severe congenital myasthenic syndromes - A recognizable clinical phenotype.
    Polavarapu K; Vengalil S; Preethish-Kumar V; Arunachal G; Nashi S; Mohan D; Chawla T; Bardhan M; Nandeesh B; Gupta P; Gowda VK; Lochmüller H; Nalini A
    Eur J Paediatr Neurol; 2021 Mar; 31():54-60. PubMed ID: 33631708
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutations in PTPN11 could lead to a congenital myasthenic syndrome phenotype: a Noonan syndrome case series.
    Pugliese A; Della Marina A; de Paula Estephan E; Zanoteli E; Roos A; Schara-Schmidt U; Hentschel A; Azuma Y; Töpf A; Thompson R; Polavarapu K; Lochmüller H
    J Neurol; 2024 Mar; 271(3):1331-1341. PubMed ID: 37923938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes-A Comprehensive Review.
    Ohno K; Ohkawara B; Shen XM; Selcen D; Engel AG
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.